Transhepatic atrial septal defect closure: simple way to achieve haemostasis in a patient with important co-morbidities

Cardiol Young. 2020 Sep;30(9):1343-1345. doi: 10.1017/S1047951120001833. Epub 2020 Jul 8.

Abstract

Percutaneous closure is the gold standard treatment for atrial septal defects, but the procedure can be complex in case of femoral thrombosis. Although unusual for congenital interventionists, transhepatic atrial septal defect closure is an attractive alternative to the internal jugular vein, especially when approaching the interatrial septum. Herein, we report the case of an adult patient with significant co-morbidities who had successful transhepatic atrial septal defect closure after a failed transjugular attempt. We describe the use of an absorbable haemostatic gelatin sponge to efficiently and safely achieve haemostasis after the use of a large vascular sheath with combined anticoagulation and antiplatelet therapy.

Keywords: Atrial septal defect; cardiac catheterisation; device closure; haemostasis; transhepatic access.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cardiac Catheterization
  • Echocardiography, Transesophageal
  • Heart Septal Defects, Atrial* / complications
  • Heart Septal Defects, Atrial* / surgery
  • Hemostasis
  • Humans
  • Jugular Veins
  • Morbidity
  • Septal Occluder Device*
  • Treatment Outcome